Preetesh Jain MBBS,MD,DM,PhD
机构: University of Texas MD Anderson Cancer Center
每年引用次数
引用次数
引用: 7,305
H-指数: 43
I10-指数 : 102
出版物: 251
NEWS & VIEWS 血液腫瘍 : CLLでのRichter's transformation : 特異なリンパ腫
Ken H. Young , Preetesh Jain
Cancer and clinical oncology 4 ( 2) 86 -88
2014
Richter's Transformation in Chronic Lymphocytic Leukemia
Susan O'Brien , Preetesh Jain
Oncology 26 ( 12) 1146 -1152
32
2012
Pattern of Mutational Changes in Patients with Chronic Phase CML Who Are Treated with Frontline TKI and Transform to Blast Phase CML
Tapan Kadia , Zeev Estrov , Farhad Ravandi , Hagop M. Kantarjian
Blood 130 4172 -4172
1
2017
Ibrutinib: A Risk Factor for Invasive Fungal Infections?
Carole Soussain , Rogier Mous , Maskit Bar-Meir , Marion Malphettes
Blood 130 4323 -4323
7
2017
Overexpression of CD36, Driven By STAT3, Mediates Free Fatty Acid Uptake in CLL Cells
Alessandra Ferrajoli , Zeev Estrov , William G Wierda , Preetesh Jain
Blood 130 4301 -4301
1
2017
Characteristics, Treatments, and Outcomes of Patients with Lymphomatoid Granulomatosis—MD Anderson Cancer Center Experience
Sattva S. Neelapu , Rashmi Kanagal-Shamanna , Jeffrey Medeiros , Nathan H. Fowler
Blood 130 2852 -2852
2017
Incidence of Secondary Malignancies in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) in the Era of Tyrosine Kinase Inhibitors (TKI)
Guillermo Garcia-Manero , Alessandra Ferrajoli , Farhad Ravandi , William G Wierda
Blood 130 1609 -1609
2017
CLL Cell-Derived Exosomes Promote Bone Marrow Fibrosis and Inhibit Normal Hematopoietic Colony Proliferation
Srdan Verstovsek , Taghi Manshouri , Alessandra Ferrajoli , Zeev Estrov
Blood 130 1728 -1728
2017
Outcomes of relapsed mantle cell lymphoma patients after discontinuing acalabrutinib
Rashmi Kanagal‐Shamanna , Chi Young Ok , Guilin Tang , Shaoying Li
American Journal of Hematology 96 ( 5)
2021
Neoadjuvant chemotherapy or chemoradiotherapy in head and neck cancer.
Preetesh Jain , Prabhash Kumar , VasanthRaghuvir Pai , PurvishMahendra Parikh
Indian Journal of Cancer 45 ( 3) 83 -89
15
2008
Prognostic Factors, Outcomes and Clinical Characteristics in Patients with Transformed Follicular Lymphoma (t-FL): Cohort Study of 172 Patients
Preetesh Jain , Loretta J. Nastoupil , Rashmi Kanagal-Shamanna , Graciela M. Nogueras González
Blood 132 1600 -1600
1
2018
Seven Year Follow up and Comparison of Dosing Strategies from the Pivotal Phase II Clinical Trial of Lenalidomide Plus Rituximab (R2) in Previously Untreated Follicular Lymphoma
Nathan H. Fowler , Preetesh Jain , Loretta J. Nastoupil , F. B. Hagemeister
Blood 132 1594 -1594
2018
Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytes
Barbara Sherry , Preetesh Jain , Pui Yan Chiu , Ling Leung
Immunologic Research 63 ( 1) 216 -227
8
2015
Long-term outcomes for patients with chronic lymphocytic leukemia who discontinue ibrutinib.
Preetesh Jain , Philip A. Thompson , Michael Keating , Zeev Estrov
Cancer 123 ( 12) 2268 -2273
59
2017
TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper‐CVAD‐based regimens
Rashmi Kanagal-Shamanna , Preetesh Jain , Koichi Takahashi , Nicholas J. Short
Cancer 123 ( 19) 3717 -3724
9
2017
Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients.
Preetesh Jain , Hagop M. Kantarjian , Ahmad Ghorab , Koji Sasaki
Cancer 123 ( 22) 4391 -4402
55
2017
Prediction for sustained deep molecular response of BCR‐ABL1 levels in patients with chronic myeloid leukemia in chronic phase
Koji Sasaki , Hagop Kantarjian , Susan O'Brien , Farhad Ravandi
Cancer 124 ( 6) 1160 -1168
20
2018
Targeted multigene deep sequencing of Bruton tyrosine kinase inhibitor–resistant chronic lymphocytic leukemia with disease progression and Richter transformation
Rashmi Kanagal‐Shamanna , Preetesh Jain , Keyur P. Patel , Mark Routbort
Cancer 125 ( 4) 559 -574
26
2019
Elevated IL-17 Producing Cells (Th17 and Non-Th17) In Different CLL Microenvironments: Correlation with Overall Survival, Prognostic Relevance and Phenotypic Heterogenity
Preetesh Jain , Mohammad Javadan , Franziska Feger , Pui Chiu
Blood 116 ( 21) 2442 -2442
1
2010
Conditional survival in patients with chronic myeloid leukemia in chronic phase in the era of tyrosine kinase inhibitors
Koji Sasaki , Hagop M. Kantarjian , Preetesh Jain , Elias J. Jabbour
Cancer 122 ( 2) 238 -248
16
2016